PRURISOL
Oral psoriasis drug candidate in a Phase 2b trial utilizing the advantages of 505(b)(2) development approach
KEVETRIN
Orphan-designated p53-modulating drug candidate in a Phase 2a trial for late-stage ovarian cancer
BRILACIDIN
An immunomodulatory drug candidate with anti-inflammatory and antibiotic properties granted Fast Track status